PASADENA, CA, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc. (Nasdaq: LIXT), a clinical-stage drug discovery company developing pharmacologically active drugs for use in cancer ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback